Dr. Henrich said the partnership will give UT Health San Antonio and its patients the opportunity to participate in enhanced clinical trials and multidisciplinary programs, according to the report.
Under the partnership, which was revealed earlier this month, MD Anderson will rebrand UT San Antonio’s cancer center to the UT Health San Antonio MD Anderson Cancer Center.
However, the cancer center will continue to operate as normal and remain a part of the UT system.
San Antonio cancer center officials also previously said the facility will reimburse MD Anderson for a portion of the costs incurred as a result of the affiliation.
More articles on transactions and valuations:
Rite Aid transfers 97 stores to Walgreens during first phase of asset sale
Texas Medical Center partners with J&J to spur medical device innovation
HCA bids $415M to purchase Indian River Medical Center
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
